Researchers can join forces with COVID-19 Collaboration Platform
More than 400 randomized clinical trials (RCTs) have been registered on clinicaltrials.gov, many are meant to answer similar questions but lack any method to combine data and evidence. By aggregating evidence across these trials, we can learn about interventions for COVID-19 as quickly and reliably as possible. The COVID-19 Collaboration Platform brings disparate research teams working on the same clinical research questions together to share protocols, data, and evidence.
CovidCP offers support managing collaborations, including expedited and prioritized help from the Trial Innovation Network and SMART IRB to form multi-site trials; expert statistical advice for aggregated analyses; and free data storage and anonymization through vivli.org. It is a partnership among over a dozen research institutions, including CTSA hubs.